Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1128 Results

Title
Intervention Indication Therapeutic Area Year Actions
Aprocitentan for treating resistant hypertension Aprocitentan (ACT-132577; AC-080; ACT 13257; Actelion) Resistant hypertension Cardiovascular System 2023 View  |  Download
Apremilast for treating moderate to severe plaque psoriasis in children and young people Apremilast (Otezla; CC-10004) Plaque psoriasis Dermatology 2023 View  |  Download
Apremilast for oral ulcers in active Beh cet’s disease Apremilast (Otezla; CC-10004) Oral ulcers Dental and Oral Health 2018 View  |  Download
Apalutamide with primary radiation therapy for treating high-risk, localised or locally advanced prostate cancer Apalutamide (Erleada; ARN-509) , Primary radiation therapy Prostate cancer Male Reproductive Cancer 2022 View  |  Download
Apalutamide in addition to androgen deprivation therapy for metastatic hormone-sensitive prostate cancer Apalutamide (Erleada; ARN-509) Prostate cancer Male Reproductive Cancer 2018 View  |  Download
Apalutamide in Addition to Abiraterone and Prednisone/Prednisolone for Metastatic Castration-resistant Prostate Cancer – First Line Abiraterone acetate (Zytiga; Yonsa) , Apalutamide (Erleada; ARN-509) , Prednisone (Decadron; Lodotra) Prostate cancer Male Reproductive Cancer 2018 View  |  Download
Apalutamide for treating high-risk, localised or locally advanced prostate cancer Apalutamide (Erleada; ARN-509) Prostate cancer Male Reproductive Cancer 2023 View  |  Download
Apadamtase alfa for treating acute thrombotic thrombocytopenic purpura (TTP) episodes associated with congenital TTP (cTTP) and long-term prophylaxis in patients with congenital ADAMTS-13 deficiency Apadamtase alfa congenital ADAMTS-13 deficiency , Thrombotic thrombocytopenic purpura Haematology 2022 View  |  Download
Apabetalone in addition to high-intensity statin therapy for preventing major adverse cardiac events in high-risk cardiovascular disease patients with type 2 diabetes mellitus Apabetalone (RVX-208) Major adverse cardiovascular events (MACE) Cardiovascular System , Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Anifrolumab for moderately to severly active, autoantibody-positive systemic lupus erythematosus Anifrolumab (MEDI546) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2020 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications